Moderna to build new vaccine facility in Britain

U.S. biotech firm Moderna will build a new research and manufacturing centre in Britain to develop vaccines against new COVID-19 variants, other respiratory illnesses and help improve readiness for any future pandemics. The agreement will see Moderna make a minimum R&D investment of 1.1 billion pounds ($1.35 billion), Prime Minister Boris Johnson's spokesman said, adding it would have the capacity for 250 million vaccines a year if needed.